These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 7169976

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R, Emond C, Claret G, Branger B, Mion H, Mion C.
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
    Chen J, Zhang J, Lin S.
    Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
    Cuppari L, Carvalho AB, Lobão RR, Martini LA, Cendoroglo M, Ventura RT, Draibe SA.
    Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clearance effect of different blood purification techniques on parathyroid hormone in renal function failure patients on maintenance hemodialysis].
    Wang C, Lou TQ, Tang H, Chen ZJ, Yin PD, Yu XQ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):753-5. PubMed ID: 15585154
    [Abstract] [Full Text] [Related]

  • 11. Immunoreactive parathyroid hormones in the circulation and cerebrospinal fluid from patients with renal failure: possible restriction of parathyroid hormone by the blood-brain barrier.
    Hironaka T, Morimoto S, Fukuo K, Koh E, Imanaka S, Sumida T, Onishi T, Kumahara Y.
    Bone Miner; 1987 Sep; 2(6):487-94. PubMed ID: 3505771
    [Abstract] [Full Text] [Related]

  • 12. [Middle molecule level and myocardial contractility in kidney patients].
    Dimitrakov D, Pisanets M.
    Vutr Boles; 1986 Sep; 25(2):18-20. PubMed ID: 3716372
    [Abstract] [Full Text] [Related]

  • 13. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice.
    Twomey PJ, Whitlock T, Pledger DR.
    J Clin Pathol; 2005 Sep; 58(9):1000-1. PubMed ID: 16126890
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure.
    Michalk D, Tschöpe W, Böhles HJ, Mehls O.
    Proc Eur Dial Transplant Assoc; 1981 Sep; 18():561-6. PubMed ID: 7329984
    [Abstract] [Full Text] [Related]

  • 16. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK, Avula S, Kher V, Rao DS, Mithal A.
    Natl Med J India; 1999 Sep; 12(5):202-7. PubMed ID: 10612998
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
    Tsuchida T, Ishimura E, Hirowatari K, Matsumoto N, Jono S, Miki T, Inaba M, Nishizawa Y.
    Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.